Study guide

12.2 Interactions & Adverse Effects

ANCC Medical-Surgical Nursing Certification MEDSURG-BC

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts: Format, Scoring, Cost 1.2 Eligibility, Application & Scheduling 1.3 Blueprint Breakdown & Study Strategy 1.4 Test-Taking Strategies for ANCC Scenario Items

2 Assessment Skills

2.1 Health History Collection 2.2 Physical Assessment 2.3 Psychosocial Assessment 2.4 Cognitive & Neurological Screening

3 Diagnostics & Clinical Reasoning

3.1 Diagnostic & Laboratory Testing 3.2 Fluids & Electrolytes 3.3 Nursing Diagnosis Identification & Prioritization

4 Cardiovascular & Hematologic

4.1 Cardiovascular Assessment & Diagnostics 4.2 Cardiovascular Disorders & Management 4.3 Hematologic Disorders & Blood Products

5 Respiratory

5.1 Respiratory Assessment & Diagnostics 5.2 Respiratory Disorders & Management 5.3 Oxygen Therapy & Ventilation Support

6 Gastrointestinal & Renal

6.1 GI Assessment & Common Disorders 6.2 GI Management & Nutrition Support 6.3 Renal & Urinary Assessment & Disorders 6.4 Acute Kidney Injury & Renal Replacement Therapies

7 Neurologic & Musculoskeletal

7.1 Neurologic Assessment & Stroke 7.2 Neurologic Disorders & Management 7.3 Musculoskeletal Assessment & Disorders 7.4 Orthopedic Care, Immobilization & Mobility

8 Endocrine, Integumentary & Immune

8.1 Endocrine Assessment & Diabetes Management 8.2 Thyroid, Adrenal & Metabolic Disorders 8.3 Integumentary Disorders & Wound Care 8.4 Immune, Infectious & Multisystem Conditions

9 Care Planning & Education

9.1 Nursing Care Planning 9.2 Patient Teaching: Process & Evaluation 9.3 Education Topics & Self-Management 9.4 Health & Wellness Promotion

10 Perioperative Care

10.1 Preoperative & Intraoperative Care 10.2 Postoperative Complication Prevention 10.3 Postoperative Emergencies: Bleeding, Infection, Emboli

11 Patient Safety

11.1 Patient Safety: Falls, Restraints & Equipment 11.2 Infection Prevention & Isolation Precautions 11.3 Recognizing Deterioration & Escalation of Care

12 Pharmacology

12.1 Safe Medication Administration 12.2 Interactions & Adverse Effects 12.3 Pain Management & Analgesics 12.4 Polypharmacy & High-Alert Medications

13 Non-Pharmacologic & Comfort Care

13.1 Non-Pharmacologic Treatments & CAM 13.2 Comfort & End-of-Life Care

14 Therapeutic Communication

14.1 Therapeutic Communication 14.2 Cultural Competence & Family-Centered Care 14.3 Difficult Conversations & Counseling

15 Interprofessional Collaboration

15.1 Interdisciplinary Team Collaboration 15.2 Delegation & Supervision 15.3 Care Coordination, Consults & Transitions

16 Ethics & Evidence-Based Practice

16.1 Nursing Ethics & Patient Advocacy 16.2 Legal & Regulatory Foundations 16.3 Evidence-Based Practice & Research 16.4 Quality Improvement & Safety Culture

12.2 Interactions & Adverse Effects

Key Takeaways Explain This Topic AI

CYP450 inhibitors raise substrate drug levels toward toxicity; inducers lower them toward therapeutic failure — warfarin, phenytoin, and theophylline are the classic victims

Hypokalemia from loop and thiazide diuretics potentiates digoxin toxicity; maintain potassium ≥ 4.0 mEq/L in patients on digoxin

NSAIDs, many antibiotics (TMP-SMX, macrolides, fluoroquinolones), and acute alcohol use all elevate the INR in patients on warfarin

Peak and trough timing matters for aminoglycosides; for serious MRSA infection, current vancomycin guidance targets AUC/MIC 400–600 rather than a universal trough of 15–20 mcg/mL

Lithium's narrow therapeutic range (0.6–1.2 mEq/L) means dehydration, NSAIDs, thiazides, and ACE inhibitors can push levels into toxicity

Last updated: August 2026

How Drug–Drug Interactions Happen

Interactions are either pharmacokinetic (what the body does to the drug — absorption, distribution, metabolism, excretion) or pharmacodynamic (what the drug does to the body — effects at receptors).

CYP450 Metabolism

The cytochrome P450 enzyme family in the liver metabolizes most drugs. Two mechanisms dominate exam questions:

Enzyme inhibitors (e.g., azole antifungals, macrolides, grapefruit juice, cimetidine) slow metabolism of a substrate drug → higher levels → toxicity

Enzyme inducers (e.g., rifampin, phenytoin, carbamazepine, St. John's wort, chronic alcohol) speed metabolism → lower levels → therapeutic failure

The drugs most often harmed are those with narrow therapeutic indexes : warfarin, phenytoin, digoxin, theophylline, lithium.

  • Pharmacodynamic Interactions
  • Additive — 1 + 1 = 2 (two sedatives)
  • Synergistic — 1 + 1 = 3 (aspirin plus warfarin on bleeding risk)
  • Antagonistic — one drug blunts another (naloxone reversing opioids; beta-agonists vs beta-blockers)
  • Classic Tested Interaction Pairs

Interaction Mechanism Nursing action

Warfarin + antibiotics (TMP-SMX, macrolides, fluoroquinolones, metronidazole) CYP inhibition and gut flora reduction (less vitamin K) Expect INR to rise; monitor closely, anticipate dose reduction

Warfarin + NSAIDs/aspirin Antiplatelet effect + GI mucosal injury Increased bleeding; avoid combination when possible

Digoxin + loop/thiazide diuretics Diuretic-induced hypokalemia potentiates digoxin toxicity Keep K⁺ ≥ 4.0 mEq/L; watch for anorexia, nausea, halos, arrhythmias

ACE inhibitor + potassium-sparing diuretic (spironolactone) or K supplements Both raise potassium Risk of hyperkalemia ; monitor K⁺

MAOI + tyramine-rich foods (aged cheese, cured meats, tap/draft beer, soy sauce) Tyramine not broken down Hypertensive crisis — teach dietary avoidance

Statins + grapefruit juice CYP3A4 inhibition raises statin levels Risk of myopathy/rhabdomyolysis; avoid grapefruit with simvastatin and atorvastatin

Also tested: MAOIs + SSRIs or meperidine → serotonin syndrome (agitation, hyperthermia, clonus — treat by stopping drugs and supportive care); aminoglycosides + loop diuretics → additive ototoxicity ; tetracyclines/fluoroquinolones + calcium, iron, antacids → chelation and poor absorption (separate by 2 hours).

Food–Drug Interactions

Vitamin K and warfarin : patients do not eliminate green leafy vegetables — they keep intake consistent week to week so the INR stays stable. Sudden increases lower the INR; sudden decreases raise it

Grapefruit juice inhibits intestinal CYP3A4 for 24–72 hours: avoid with many statins, calcium channel blockers (felodipine, nifedipine), amiodarone, and some benzodiazepines

  • Dairy/calcium chelates tetracyclines and fluoroquinolones
  • High-protein meals can reduce levodopa absorption
  • Enteral feedings bind phenytoin — hold tube feeds 1–2 hours before and after the dose
  • Adverse Drug Reaction Taxonomy
  • Side effect — predictable, often unavoidable effect at therapeutic doses (dry mouth from anticholinergics)

Adverse drug reaction (ADR) — any noxious, unintended response at normal doses; includes side effects but implies harm

Toxicity — dose-related organ damage (aminoglycoside nephrotoxicity); often predictable from levels

Idiosyncratic reaction — unpredictable, genetically based, not dose-related (e.g., hemolysis in G6PD deficiency)

  • Allergic (hypersensitivity) reaction — immune-mediated, not dose-related
  • Allergic Severity and Anaphylaxis

Reactions range from mild urticaria to anaphylaxis , a life-threatening type I hypersensitivity with airway edema, bronchospasm, and hypotension. Priorities: stop the drug, maintain the airway, give epinephrine 0.3–0.5 mg IM (1:1,000) into the anterolateral thigh — epinephrine is always first, before antihistamines or steroids. Then position flat with legs elevated, high-flow oxygen, IV fluids, and monitor for a biphasic reaction. Document the allergy and notify pharmacy; a true allergy is never "tested" by re-challenge outside a controlled setting.

Black Box Warnings

A black box warning is the FDA's strongest labeling alert for serious or fatal risks. Examples to know: fluoroquinolones (tendon rupture), clozapine (agranulocytosis), valproate (hepatotoxicity, teratogenicity), opioids (respiratory depression), and metoclopramide (tardive dyskinesia).

Cross-Reactivity and Severe Cutaneous Reactions

Penicillin–cephalosporin cross-reactivity is lower than the historically quoted 10% (closer to 1–2%), but a patient with a documented anaphylactic penicillin reaction should not receive a cephalosporin without specialist evaluation. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening mucocutaneous reactions triggered by drugs such as sulfonamides, allopurinol, lamotrigine, and carbamazepine — a new rash with mucosal lesions or blistering after starting one of these drugs means stop it and escalate immediately. Distinguish serotonin syndrome (hyperreflexia, clonus, rapid onset, serotonergic drugs) from neuroleptic malignant syndrome (lead-pipe rigidity, slow onset over days, dopamine antagonists, elevated CK); both cause hyperthermia and both require stopping the offending drug.

Monitoring Labs Nurses Must Know

Drug Key lab Target/toxicity

Aminoglycosides (gentamicin) Peak 30–60 min after infusion; trough just before next dose Gentamicin trough >2 mcg/mL → nephro-/ototoxicity risk

Vancomycin Use AUC-guided monitoring for serious MRSA infection Target AUC/MIC 400–600 when MIC is assumed 1 mg/L; monitor renal function and infusion reaction risk

Lithium Level 12 hours after last dose Therapeutic 0.6–1.2 mEq/L; toxicity >1.5; severe >2.5 (tremor, confusion, seizures). Dehydration, low sodium, NSAIDs, thiazides, ACE inhibitors raise levels

Digoxin Level 6–8 hours post dose Therapeutic 0.5–2.0 ng/mL (often 0.5–0.9 for heart failure); hold and notify for apical pulse <60 bpm or signs of toxicity

  • Warfarin INR 2.0–3.0 for most indications; 2.5–3.5 for mechanical mitral valves
  • Heparin aPTT or anti-Xa Follow protocol nomograms
  • Phenytoin Level Therapeutic 10–20 mcg/mL
  • Theophylline Level Therapeutic 10–20 mcg/mL